Pets or meat? Doesn't matter, Pfizer's Zoetis gains on both

Pfizer's ($PFE) animal health group Zoetis goes public today, with an IPO valued at up to $2.2 billion. How will Zoetis fare as a public animal-health behemoth? Pretty well, experts figure, if global trends toward meat consumption and companion animals continue. Report

Suggested Articles

Turns out Procter & Gamble didn’t want Pfizer’s consumer health unit after all. But it did want Merck KGaA’s.

Johnson & Johnson faces a litany of problems, but executives are clearly not concerned—at least not about the company's short-term fortunes.

Private equity firm, in exclusive talks with Sanofi, says it'll invest to pump up Zentiva into an "independent European generics leader."